Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Soo Yoon

Showing results (951-960 of 1,104) with videos related to

Pageof 111
Sort By:
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
Current Problems in Cancer|August 29, 2021
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk featuresKwai Han Yoo, Dok Hyun Yoon, Hye Jin Kang, et al.
Annals of Hematology|July 1, 2023
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)Mihee Kim, Je-Jung Lee, Chang-Ki Min, et al.
Journal of Cellular Physiology|October 24, 2006
Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cellsJun Sik Lee, Sang Gap Kim, Hyung Keun Kim, et al.
Biological & Pharmaceutical Bulletin|December 5, 2006
Ginseng saponins diminish adverse vascular effects associated with chronic methionine-induced hyperhomocysteinemiaJong-Hoon Kim, Soo Yeun Cho, Chang-Won Kang, et al.
Frontiers in Nutrition|December 5, 2024
Post-harvest processed parsnip showed improved anti-oxidative capacity and protective potential against acrolein-induced inflammation <i>in vitro</i> and <i>in vivo</i>Kangwook Lee, Jeong Hoon Pan, La Yoon Choi, et al.
International Journal of Hematology|March 21, 2014
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesYundeok Kim, In-Ho Kim, Hyeong Joon Kim, et al.
International Journal of Cancer|March 15, 2025
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective studySeug Yun Yoon, Sung-Soo Yoon, Deok-Hwan Yang, et al.
Cancer Research and Treatment|June 2, 2026
Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)Jun Ho Yi, Sang Eun Yoon, Ji Hyun Lee, et al.
Cells|December 5, 2019
Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK RearrangementJi-Hyun Kwon, Kui-Jin Kim, Ji Hea Sung, et al.
Pageof 111

Showing results (951-960 of 1,104) with videos related to

Sort By:
Pageof 111
Annals of Hematology|January 13, 2016
Prognostic factors for re-mobilization using plerixafor and granulocyte colony-stimulating factor (G-CSF) in patients with malignant lymphoma or multiple myeloma previously failing mobilization with G-CSF with or without chemotherapy: the Korean multicenter retrospective studyJin Seok Kim, Dok Hyun Yoon, Seonyang Park, et al.
Current Problems in Cancer|August 29, 2021
Multicenter, phase II study of response-adapted lenalidomide-based therapy for transplant-ineligible patients with newly diagnosed multiple myeloma without high-risk featuresKwai Han Yoo, Dok Hyun Yoon, Hye Jin Kang, et al.
Annals of Hematology|July 1, 2023
Busulfan plus melphalan versus high-dose melphalan as a conditioning regimen for autologous stem cell transplantation in multiple myeloma with high-risk features (KMM 2015)Mihee Kim, Je-Jung Lee, Chang-Ki Min, et al.
Journal of Cellular Physiology|October 24, 2006
Silibinin polarizes Th1/Th2 immune responses through the inhibition of immunostimulatory function of dendritic cellsJun Sik Lee, Sang Gap Kim, Hyung Keun Kim, et al.
Biological & Pharmaceutical Bulletin|December 5, 2006
Ginseng saponins diminish adverse vascular effects associated with chronic methionine-induced hyperhomocysteinemiaJong-Hoon Kim, Soo Yeun Cho, Chang-Won Kang, et al.
Frontiers in Nutrition|December 5, 2024
Post-harvest processed parsnip showed improved anti-oxidative capacity and protective potential against acrolein-induced inflammation <i>in vitro</i> and <i>in vivo</i>Kangwook Lee, Jeong Hoon Pan, La Yoon Choi, et al.
International Journal of Hematology|March 21, 2014
Multicenter study evaluating the impact of hypomethylating agents as bridging therapy to hematopoietic stem cell transplantation in myelodysplastic syndromesYundeok Kim, In-Ho Kim, Hyeong Joon Kim, et al.
International Journal of Cancer|March 15, 2025
Hematologic and molecular responses to ropeginterferon alfa-2b therapy of polycythemia vera: 48-week results from a prospective studySeug Yun Yoon, Sung-Soo Yoon, Deok-Hwan Yang, et al.
Cancer Research and Treatment|June 2, 2026
Randomized Phase II Study of Bortezomib, Lenalidomide, and Dexamethasone (VRD) Versus Lenalidomide and Dexamethasone (RD) in Elderly Patients with Newly Diagnosed Multiple Myeloma (KMM1910)Jun Ho Yi, Sang Eun Yoon, Ji Hyun Lee, et al.
Cells|December 5, 2019
Afatinib Overcomes Pemetrexed-Acquired Resistance in Non-Small Cell Lung Cancer Cells Harboring an EML4-ALK RearrangementJi-Hyun Kwon, Kui-Jin Kim, Ji Hea Sung, et al.
Pageof 111